AI takes on breast cancer: could a computer pick better treatment than standard care?

This study tests whether an artificial intelligence (AI) model can choose the best combination of targeted drugs for women with HER2-positive breast cancer before surgery. About 280 women with early or locally advanced breast cancer will be randomly assigned to either AI-guided therapy or standard therapy. The goal is to see if the AI approach leads to a higher rate of complete cancer disappearance at the time of surgery.